CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 55 enrolled
Drug / intervention
Jetstream Atherectomy Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01273623
NCT01273623Phase 4Completed
CompareCT.gov

A Prospective, Single-Arm Study to Evaluate the Effects of the Jetstream G3 System on Calcified Peripheral Vascular Lesions

Boston Scientific Corporation·interventional·Posted Jan 10, 2011·Updated Nov 18, 2015

In Brief

A Phase 4 clinical trial evaluating Jetstream Atherectomy System for Peripheral Arterial Disease. Completed, enrolled 55 participants across 5 sites.

Detailed Summary

To investigate the treatment effects with the Jetstream G3 System in moderate to severely calcified peripheral artery disease in the common femoral, superficial femoral or popliteal arteries using intravascular ultrasound (IVUS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 10, 2011
Enrollment StartJan 1, 2011
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.5 years ago

Interventions

Jetstream Atherectomy Systemdevice

to perform atherectomy on calcified lesions